Moreover, CD8+ tumor-infiltrating lymphocytes expressing PDCD1 (encoding PD-1) and Cytotoxic T-Lymphocyte Antigen 4 (CTLA-4) correlate with response to checkpoint blockade therapy and survival in melanoma patients [212]. This evidence concerns the gene CD8A and neoplasm.